chr16-81786163-T-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_002661.5(PLCG2):​c.174T>C​(p.Ala58Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.698 in 1,613,708 control chromosomes in the GnomAD database, including 394,472 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.69 ( 36283 hom., cov: 33)
Exomes 𝑓: 0.70 ( 358189 hom. )

Consequence

PLCG2
NM_002661.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7O:1

Conservation

PhyloP100: -3.07
Variant links:
Genes affected
PLCG2 (HGNC:9066): (phospholipase C gamma 2) The protein encoded by this gene is a transmembrane signaling enzyme that catalyzes the conversion of 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate to 1D-myo-inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG) using calcium as a cofactor. IP3 and DAG are second messenger molecules important for transmitting signals from growth factor receptors and immune system receptors across the cell membrane. Mutations in this gene have been found in autoinflammation, antibody deficiency, and immune dysregulation syndrome and familial cold autoinflammatory syndrome 3. [provided by RefSeq, Mar 2014]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.66).
BP6
Variant 16-81786163-T-C is Benign according to our data. Variant chr16-81786163-T-C is described in ClinVar as [Benign]. Clinvar id is 403316.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-81786163-T-C is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-3.07 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.853 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PLCG2NM_002661.5 linkc.174T>C p.Ala58Ala synonymous_variant Exon 2 of 33 ENST00000564138.6 NP_002652.2 P16885
PLCG2NM_001425749.1 linkc.174T>C p.Ala58Ala synonymous_variant Exon 3 of 34 NP_001412678.1
PLCG2NM_001425750.1 linkc.174T>C p.Ala58Ala synonymous_variant Exon 2 of 33 NP_001412679.1
PLCG2NM_001425751.1 linkc.174T>C p.Ala58Ala synonymous_variant Exon 3 of 34 NP_001412680.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PLCG2ENST00000564138.6 linkc.174T>C p.Ala58Ala synonymous_variant Exon 2 of 33 1 NM_002661.5 ENSP00000482457.1 P16885

Frequencies

GnomAD3 genomes
AF:
0.689
AC:
104674
AN:
152006
Hom.:
36262
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.644
Gnomad AMI
AF:
0.513
Gnomad AMR
AF:
0.730
Gnomad ASJ
AF:
0.669
Gnomad EAS
AF:
0.874
Gnomad SAS
AF:
0.768
Gnomad FIN
AF:
0.748
Gnomad MID
AF:
0.687
Gnomad NFE
AF:
0.682
Gnomad OTH
AF:
0.668
GnomAD2 exomes
AF:
0.727
AC:
180856
AN:
248772
AF XY:
0.727
show subpopulations
Gnomad AFR exome
AF:
0.641
Gnomad AMR exome
AF:
0.779
Gnomad ASJ exome
AF:
0.684
Gnomad EAS exome
AF:
0.876
Gnomad FIN exome
AF:
0.752
Gnomad NFE exome
AF:
0.689
Gnomad OTH exome
AF:
0.703
GnomAD4 exome
AF:
0.699
AC:
1020982
AN:
1461586
Hom.:
358189
Cov.:
51
AF XY:
0.700
AC XY:
509115
AN XY:
727082
show subpopulations
African (AFR)
AF:
0.643
AC:
21536
AN:
33476
American (AMR)
AF:
0.774
AC:
34584
AN:
44704
Ashkenazi Jewish (ASJ)
AF:
0.679
AC:
17732
AN:
26134
East Asian (EAS)
AF:
0.891
AC:
35361
AN:
39700
South Asian (SAS)
AF:
0.768
AC:
66261
AN:
86238
European-Finnish (FIN)
AF:
0.744
AC:
39712
AN:
53400
Middle Eastern (MID)
AF:
0.710
AC:
4069
AN:
5730
European-Non Finnish (NFE)
AF:
0.683
AC:
759881
AN:
1111828
Other (OTH)
AF:
0.693
AC:
41846
AN:
60376
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
15929
31858
47786
63715
79644
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19542
39084
58626
78168
97710
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.689
AC:
104736
AN:
152122
Hom.:
36283
Cov.:
33
AF XY:
0.696
AC XY:
51787
AN XY:
74356
show subpopulations
African (AFR)
AF:
0.643
AC:
26698
AN:
41490
American (AMR)
AF:
0.730
AC:
11165
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.669
AC:
2324
AN:
3472
East Asian (EAS)
AF:
0.874
AC:
4516
AN:
5168
South Asian (SAS)
AF:
0.768
AC:
3697
AN:
4814
European-Finnish (FIN)
AF:
0.748
AC:
7918
AN:
10582
Middle Eastern (MID)
AF:
0.695
AC:
203
AN:
292
European-Non Finnish (NFE)
AF:
0.682
AC:
46339
AN:
67986
Other (OTH)
AF:
0.665
AC:
1408
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1722
3444
5165
6887
8609
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
828
1656
2484
3312
4140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.686
Hom.:
53264
Bravo
AF:
0.686
Asia WGS
AF:
0.747
AC:
2598
AN:
3478
EpiCase
AF:
0.683
EpiControl
AF:
0.683

ClinVar

Significance: Benign
Submissions summary: Benign:7Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2Other:1
-
GenomeConnect, ClinGen
Significance:not provided
Review Status:no classification provided
Collection Method:phenotyping only

Variant interpreted as Benign and reported on 04-27-2020 by Lab or GTR ID 500031. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. This variant was reported in an individual referred for clinical diagnostic genetic testing. -

May 04, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:2
Nov 12, 2023
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 95% of patients studied by a panel of primary immunodeficiencies. Number of patients: 91. Only high quality variants are reported. -

Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

Familial cold autoinflammatory syndrome 3 Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 25, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autoinflammation-PLCG2-associated antibody deficiency-immune dysregulation Benign:1
Oct 25, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.66
CADD
Benign
0.25
DANN
Benign
0.76
PhyloP100
-3.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1143685; hg19: chr16-81819768; COSMIC: COSV108182756; API